Fulton Hogan proudly supporting the work of Endometriosis New Zealand
12 April 2016 – under embargo until 7pm
Fulton Hogan today announced its sponsorship of Endometriosis New Zealand, providing funding over the next 12 months to
assist with research and educational programmes.
Fulton Hogan New Zealand CEO Robert Jones said that his company is determined to help remove barriers and provide
support which will increase education and improve the treatment of endometriosis, which is a disease suffered by one in
10 women.
“We are inspired by the work of Endometriosis New Zealand and we are set on playing a role in increasing awareness of
the condition,” Mr Jones said.
“While some may feel that an infrastructure company supporting this cause is an unusual fit, we think the opposite,” Mr
Jones said. “Like us, Endometriosis New Zealand works hard as an industry leader to provide services, support and
connections for its community.
“We see our two organisations as sharing similar values and we’re proud to be able to support the work it does.”
As part of the sponsorship agreement, Fulton Hogan will provide a research grant that will fund the study of
endometriosis in adolescents. This will be conducted by a collaborative team of researchers from the University of
Adelaide, University of Melbourne and University of Canberra.
Fulton Hogan will also fund Endometriosis New Zealand’s educational programme in Auckland and Wellington secondary
schools. The ‘me’ programme (which stands for Menstrual Health and Endometriosis) has been delivered to secondary
schools across the country since 1995 and is an important way of raising awareness among younger audiences.
Endometriosis New Zealand CEO Deborah Bush said she is grateful to have Fulton Hogan on board.
“We wish to thank Fulton Hogan for its generous support of our cause,” Mrs Bush said. “One in 10 women suffer from
endometriosis – along with a significant percentage of women who go undiagnosed – so it is an issue we cannot afford to
ignore.
“With the backing of Fulton Hogan, we’ll be able to do more in our pursuit to improve education and treatment.”
ENDS